CD14 and COVID-19: Critically, our findings point to a likely selective role for COVID-19 severity-associated genetic variants in modulating disease responses in selective cell states, including in immature CD14+ monocyte populations in the setting of infection with SARS-CoV-2; they also suggest that many regulatory elements in which the risk variants reside may not be active in healthy donors.